Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 935

1.

Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study.

Avontuur JA, Tutein Nolthenius RP, van Bodegom JW, Bruining HA.

Crit Care Med. 1998 Apr;26(4):660-7.

PMID:
9559602
[PubMed - indexed for MEDLINE]
2.

Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock.

Avontuur JA, Tutein Nolthenius RP, Buijk SL, Kanhai KJ, Bruining HA.

Chest. 1998 Jun;113(6):1640-6.

PMID:
9631805
[PubMed - indexed for MEDLINE]
3.

Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF alpha and nitrite/nitrate in human septic shock.

Avontuur JA, Stam TC, Jongen-Lavrencic M, van Amsterdam JG, Eggermont AM, Bruining HA.

Intensive Care Med. 1998 Jul;24(7):673-9.

PMID:
9722036
[PubMed - indexed for MEDLINE]
4.

Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock.

Kiehl MG, Ostermann H, Meyer J, Kienast J.

Intensive Care Med. 1997 May;23(5):561-6.

PMID:
9201529
[PubMed - indexed for MEDLINE]
5.

Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).

Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR; Glaxo Wellcome International Septic Shock Study Group.

Crit Care Med. 2004 Jan;32(1):13-20.

PMID:
14707555
[PubMed - indexed for MEDLINE]
6.

Pulmonary hypertension and reduced cardiac output during inhibition of nitric oxide synthesis in human septic shock.

Avontuur JA, Biewenga M, Buijk SL, Kanhai KJ, Bruining HA.

Shock. 1998 Jun;9(6):451-4.

PMID:
9645498
[PubMed - indexed for MEDLINE]
7.

Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia.

Meyer J, Lentz CW, Stothert JC Jr, Traber LD, Herndon DN, Traber DL.

Crit Care Med. 1994 Feb;22(2):306-12.

PMID:
8306691
[PubMed - indexed for MEDLINE]
8.

Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock.

Robertson FM, Offner PJ, Ciceri DP, Becker WK, Pruitt BA Jr.

Arch Surg. 1994 Feb;129(2):149-55; discussion 155-6.

PMID:
7508219
[PubMed - indexed for MEDLINE]
9.

Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock.

Broccard A, Hurni JM, Eckert P, Liaudet L, Schaller MD, Lazor R, Perret C, Feihl F.

Shock. 2000 Jul;14(1):35-40.

PMID:
10909891
[PubMed - indexed for MEDLINE]
10.

Effect of combined nitric oxide inhalation and NG-nitro-L-arginine infusion in porcine endotoxin shock.

Weitzberg E, Rudehill A, Modin A, Lundberg JM.

Crit Care Med. 1995 May;23(5):909-18.

PMID:
7736750
[PubMed - indexed for MEDLINE]
11.

Effects of a nitric oxide synthase inhibitor in humans with septic shock.

Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P.

Cardiovasc Res. 1994 Jan;28(1):34-9.

PMID:
7509259
[PubMed - indexed for MEDLINE]
12.

Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).

Bakker J, Grover R, McLuckie A, Holzapfel L, Andersson J, Lodato R, Watson D, Grossman S, Donaldson J, Takala J; Glaxo Wellcome International Septic Shock Study Group.

Crit Care Med. 2004 Jan;32(1):1-12.

PMID:
14707554
[PubMed - indexed for MEDLINE]
13.

Comparison between selective and nonselective nitric oxide synthase inhibition and phenylephrine in normal and endotoxic swine.

Cohen RI, Shapir Y, Davis A, Loona R, Scharf SM.

Crit Care Med. 2000 Sep;28(9):3257-67.

PMID:
11008990
[PubMed - indexed for MEDLINE]
14.

An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.

Grover R, Zaccardelli D, Colice G, Guntupalli K, Watson D, Vincent JL.

Crit Care Med. 1999 May;27(5):913-22.

PMID:
10362413
[PubMed - indexed for MEDLINE]
15.

Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep.

Booke M, Hinder F, McGuire R, Traber LD, Traber DL.

Crit Care Med. 1996 May;24(5):835-44.

PMID:
8706462
[PubMed - indexed for MEDLINE]
16.

The effect of the nitric oxide synthesis inhibitor L-NAME on amitriptyline-induced hypotension in rats.

Tuncok Y, Kalkan S, Murat N, Arkan F, Guven H, Aygoren O, Kurt S.

J Toxicol Clin Toxicol. 2002;40(2):121-7.

PMID:
12126183
[PubMed - indexed for MEDLINE]
17.

L-arginine pathway in the sepsis syndrome.

Lorente JA, Landín L, De Pablo R, Renes E, Liste D.

Crit Care Med. 1993 Sep;21(9):1287-95.

PMID:
8370291
[PubMed - indexed for MEDLINE]
18.

Endothelin-1 and blood pressure after inhibition of nitric oxide synthesis in human septic shock.

Avontuur JA, Boomsma F, van den Meiracker AH, de Jong FH, Bruining HA.

Circulation. 1999 Jan 19;99(2):271-5.

PMID:
9892594
[PubMed - indexed for MEDLINE]
Free Article
19.

NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension.

Kilbourn RG, Fonseca GA, Griffith OW, Ewer M, Price K, Striegel A, Jones E, Logothetis CJ.

Crit Care Med. 1995 Jun;23(6):1018-24.

PMID:
7774211
[PubMed - indexed for MEDLINE]
20.

Inhibition of exhaled nitric oxide production during sepsis does not prevent lung inflammation.

Aaron SD, Valenza F, Volgyesi G, Mullen JB, Slutsky AS, Stewart TE.

Crit Care Med. 1998 Feb;26(2):309-14.

PMID:
9468170
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk